Use of oral cephalosporins in the treatment of acute otitis media in children

International Journal of Antimicrobial Agents
Itzhak Brook

Abstract

The selection of the most effective antimicrobial to treat acute otitis media (AOM) has become more difficult in recent years because of increasing antibiotic resistance among all AOM pathogens. Resistance of Streptococcus pneumoniae to penicillin as well as amoxicillin ranges from 30 to 55% in the USA. Currently, 40-55% of Haemophilus influenzae and 90-100% of Moraxella catarrhalis are resistant to penicillin because of the production of Beta-lactamases. This review discusses the availability of oral cephalosporins that can be utilised for the treatment of AOM in children. An evaluation is made regarding their in vitro activity against the pathogens, their middle-ear concentrations, pharmacokinetics and pharmacodynamics (PK/PD). The cephalosporins that will be discussed are cefuroxime-axetil, cefprozil, cefdinir and cefpodoxime-proxetil. The current recommendations for therapy of AOM limit the choices of clinicians to a single cephalosporin (cefuroxime-axetil). However, clinical, bacteriological and PK/PD data shows that several other cephalosporins (cefprozil, cefdinir and cefpodoxime-proxetil) possess similar indices which provide the clinician with wider therapeutic choices that can insure better compliance and ultimately b...Continue Reading

References

Jan 1, 1987·Reviews of Infectious Diseases·G F Van HareC H Kim
Jun 8, 1995·The New England Journal of Medicine·S Berman
Feb 1, 1997·The Pediatric Infectious Disease Journal·I Brook, A E Gober
Feb 10, 1998·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·W A Craig
Nov 3, 1998·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·G V DoernR N Jones
Jan 28, 1999·The New England Journal of Medicine·T HeikkinenT Chonmaitree
Feb 29, 2000·The Pediatric Infectious Disease Journal·R DaganM R Jacobs
Apr 5, 2000·The Pediatric Infectious Disease Journal·D P McCormickT Chonmaitree
Jan 6, 2001·The Pediatric Infectious Disease Journal·D R Guay
Feb 15, 2001·The New England Journal of Medicine·J EskolaUNKNOWN Finnish Otitis Media Study Group
Jan 16, 2002·The Pediatric Infectious Disease Journal·Arnon BroidesTikva Yermiahu
May 3, 2002·Pediatrics·Birgit WintherJ Owen Hendley
Dec 21, 2002·European Journal of Pediatrics·Steven Black, Henry Shinefield
Apr 23, 2003·Vaccine·Katherine L O'Brien, Ron Dagan

❮ Previous
Next ❯

Citations

Apr 26, 2006·Expert Opinion on Emerging Drugs·Avner AliphasKenneth M Grundfast
Aug 21, 2007·International Journal of Pediatric Otorhinolaryngology·Kari Jorunn KvaernerGunnhild Karevold
Jun 5, 2007·International Journal of Pediatric Otorhinolaryngology·Kari J Kvaerner, Anja B Helgaker
Feb 18, 2014·International Journal of Biological Macromolecules·P ShobharaniN M Sachindra

❮ Previous
Next ❯

Related Concepts

Related Feeds

Bacterial Pneumonia (ASM)

Bacterial pneumonia is a prevalent and costly infection that is a significant cause of morbidity and mortality in patients of all ages. Here is the latest research.

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Bacterial Pneumonia

Bacterial pneumonia is a prevalent and costly infection that is a significant cause of morbidity and mortality in patients of all ages. Here is the latest research.

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Related Papers

Current Infectious Disease Reports
R L Wientzen, C Barbey-Morel
Pediatrics
American Academy of Pediatrics Subcommittee on Management of Acute Otitis Media
Current Infectious Disease Reports
C F Decker
© 2022 Meta ULC. All rights reserved